Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.500
+0.045 (3.09%)
At close: Sep 17, 2025, 4:00 PM EDT
1.600
+0.100 (6.67%)
After-hours: Sep 17, 2025, 7:29 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $8.74 million as of September 17, 2025. Its market cap has decreased by -51.67% in one year.
Market Cap
8.74M
Enterprise Value
-7.79M
1-Year Change
-51.67%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $8.74M, a decrease of -53.85%. That is a compound annual growth rate of -20.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 8.48M | -52.60% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |